WPI 1118 (Mirtazapine 30 mg)

Pill imprint WPI 1118 has been identified as Mirtazapine 30 mg.

Mirtazapine is used in the treatment of insomnia; major depressive disorder; anxiety; depression; hot flashes (and more), and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy. Mirtazapine 30 mg is not a controlled substance under the Controlled Substance Act (CSA).

Mirtazapine

Imprint:

WPI 1118

Strength:

30 mg

Color:

Yellow

Size:

13.00 mm

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Tetracyclic antidepressants

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Watson Pharmaceuticals

National Drug Code (NDC):

00591-1118

Inactive Ingredients:

lactose anhydrous
silicon dioxide
magnesium stearate
microcrystalline cellulose
hypromellose 2910 (3 mPa.s)
hypromellose 2910 (6 mPa.s)
polyethylene glycol 400
polysorbate 80
titanium dioxide
ferric oxide yellow

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
16590-0154	Stat RX USA LLC (repackager)
68258-7005	Dispensing Solutions Inc. (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.